Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jeffrey Alan Jones currently holds 39,478 shares of Cullinan Oncology, Inc. (CGEM), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jeffrey Alan Jones has been a net buyer of CGEM stock. They have purchased $134.7K and sold $80.8K worth of shares.
Jeffrey Alan Jones's most recent insider trade was on Jul 14, 2026, when they sold 45,728 shares at $19.00 per share.
Jeffrey Alan Jones serves as Executive at Cullinan Oncology, Inc. (CGEM). They have executed 19 insider transactions totaling $215.5K over their tenure at the company.
Jeffrey Alan Jones holds the position of Executive at Cullinan Oncology, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Jeffrey Alan Jones has shown a buying trading pattern, with $134.7K in total purchases and $80.8K in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Jeffrey Alan Jones was on Jul 14, 2026, when they sold $868.8K worth of WSR shares. This transaction involved 45,728 shares at $19.00 per share.
Jeffrey Alan Jones currently owns 39,478 shares of Cullinan Oncology, Inc. (CGEM), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jeffrey Alan Jones's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jeffrey Alan Jones has 19 Form 4 filings on record as an insider at Cullinan Oncology, Inc..
Set alerts for Jeffrey Alan Jones and 40,000+ other insiders.